1. Home
  2. STXS vs AXR Comparison

STXS vs AXR Comparison

Compare STXS & AXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • AXR
  • Stock Information
  • Founded
  • STXS 1990
  • AXR 1961
  • Country
  • STXS United States
  • AXR United States
  • Employees
  • STXS N/A
  • AXR N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • AXR Homebuilding
  • Sector
  • STXS Health Care
  • AXR Real Estate
  • Exchange
  • STXS Nasdaq
  • AXR Nasdaq
  • Market Cap
  • STXS 189.8M
  • AXR 203.2M
  • IPO Year
  • STXS 2004
  • AXR N/A
  • Fundamental
  • Price
  • STXS $2.27
  • AXR $31.70
  • Analyst Decision
  • STXS Strong Buy
  • AXR
  • Analyst Count
  • STXS 2
  • AXR 0
  • Target Price
  • STXS $4.50
  • AXR N/A
  • AVG Volume (30 Days)
  • STXS 457.1K
  • AXR 34.9K
  • Earning Date
  • STXS 11-11-2024
  • AXR 12-31-2024
  • Dividend Yield
  • STXS N/A
  • AXR N/A
  • EPS Growth
  • STXS N/A
  • AXR N/A
  • EPS
  • STXS N/A
  • AXR 2.30
  • Revenue
  • STXS $25,143,000.00
  • AXR $63,223,000.00
  • Revenue This Year
  • STXS $1.16
  • AXR N/A
  • Revenue Next Year
  • STXS $55.65
  • AXR N/A
  • P/E Ratio
  • STXS N/A
  • AXR $13.88
  • Revenue Growth
  • STXS N/A
  • AXR 54.34
  • 52 Week Low
  • STXS $1.66
  • AXR $15.88
  • 52 Week High
  • STXS $3.29
  • AXR $39.67
  • Technical
  • Relative Strength Index (RSI)
  • STXS 51.98
  • AXR 38.66
  • Support Level
  • STXS $2.20
  • AXR $30.29
  • Resistance Level
  • STXS $2.46
  • AXR $33.50
  • Average True Range (ATR)
  • STXS 0.14
  • AXR 1.97
  • MACD
  • STXS -0.01
  • AXR -0.91
  • Stochastic Oscillator
  • STXS 42.71
  • AXR 7.57

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.

About AXR AMREP Corporation

Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.

Share on Social Networks: